Researchers have developed a new multiple organ-on-chip system to help study how neurotoxins move from the gut to the brain. The model system simulated how a neurotoxin in the gut can trigger the brain cell death seen in Parkinson’s disease, in a proof-of-concept study from the Quadram Institute, University of Hull, University of Essex and at the UK Health Security Agency (UKHSA).

Titian Software (“Titian”), a market leader in life sciences sample management software, has announced that Griffith University’s Compounds Australia, Australia’s only dedicated compound management facility, has selected Titian’s Mosaic Sample Management platform (“Mosaic”) to manage their extensive compound collection and support future growth. Mosaic will enable optimisation of workflow efficiencies at Compounds Australia, underpinning the facility’s strategic growth to meet the needs of a growing drug discovery sector. ..

Clinisys WinPath go-lives at Northern Health and Social Care Trust and the cervical cytology screening service complete phase three of the CoreLIMS programme to transform pathology services across the country. The transformation of pathology services across Northern Ireland has achieved another milestone, with the completion of phase three of the CoreLIMS programme to deploy Clinisys WinPath to all five health and social care trusts and the blood transfusion service...

Revvity, Inc. has announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom. Building on the parties’ long and productive work history, this advanced collaboration is dedicated to accelerating Genomics England’s renowned research programs, supporting diverse areas in genomics, and fostering talent in innovative healthcare fields...

Spin-out ChromaTwist has won a prestigious Innovate UK Smart grant to co-fund a £0.5m project. The funding from Innovate UK, the UK’s innovation agency, covers 70% of the cost of a project that will take ChromaTwist’s novel dyes to the next level in terms of enhanced brightness and staining indices, to make cells and cellular structures stand out more clearly during bio-imaging...

After successful sandpit events in Liverpool and London earlier this year, iiCON (Infection Innovation Consortium) is excited to announce 11 new projects during World AMR Awareness Week. These projects are focused on combating infectious diseases and have received a share of £1.5 million in funding from UKRI as part of its ongoing work to support innovative ways of tackling infections...

Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about how these cancers develop and grow. However, the research team found something incredible that could lead to a way to treat not just breast and prostate cancers but all cancers. Through MicroQuin’s ISS National Lab-sponsored research, the team identified microgravity-induced changes in cancer cell signaling that revealed something critical to cancer cell survival...

Whether discovering new materials or working to overcome challenges with existing products, scanning electron microscopy (SEM) is a valuable instrument for industry. Here, Britta Siefer, Senior Sales Account Manager at industrial SEM specialist Thermo Fisher Scientific, explains the considerations when investing in an SEM microscope for an industrial application...

Thermo Fisher Scientific and Society for Science have announced the winners of the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation’s premier middle school science, technology, engineering and math (STEM) competition. Tina Jin, 13, from San Jose, Calif., won the $25,000 Thermo Fisher Scientific ASCEND (Aspiring Scientists Cultivating Exciting New Discoveries) Award, the top prize in the competition...

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, according to researchers. A team from The Institute of Cancer Research, London, has developed a new immuno-PET imaging technique that could spot which glioblastoma patients would respond well to immunotherapy, and track the response over time...

INTEGRA Biosciences’ pipettes are being used by bioanalytical consultancy BioApp Solutions to semi-automate and streamline its repetitive liquid handling protocols. The devices have enabled the company to improve pipetting consistency within its sample analysis and method development workflows, ensuring more reproducible results. BioApp was established in Leeds, UK, in 2015 as a specialist provider of bioanalytical training and consultancy services...

Colossal, the de-extinction and species preservation company, announces numerous breakthrough successes in all stages of the thylacine de-extinction effort that put the company much closer to returning the iconic thylacine to Australia. From the generation of the highest quality ancient genome to date, to breaking records in multiplex genome editing, to innovations in assisted reproductive technologies for marsupials...

EIBF, the UK registered charity that promotes business education for engineers and scientists, and the National Physical Laboratory (NPL), the UK’s National Metrology Institute, are partnering on an MBA scholarship scheme that will provide business education for scientists. The collaboration will provide MBA scholarships worth £50,000 to eight UK science graduates each year...

Biotech Fluidics reports that renowned experts in liquid chromatography – Dr Maisch HPLC GmbH has installed a Biotech Liquid Micro Flow Meter in its testing set-up to validate the performance of all capillary columns it manufactures. Based in the Southwest of Germany – Dr Maisch has over the last 45 years earned a reputation as a leading developer of high-quality standard and specialist capillary columns for HPLC and UHPLC...

RAPT Therapeutics in San Francisco, USA, relies on INTEGRA Biosciences’ pipettes to seamlessly accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers. These liquid handling solutions help the company’s R&D team to efficiently analyze its lead drug candidates at every stage of the process – from discovery to clinical trials – driving its innovative therapies towards commercialization...

David Baker, Demis Hassabis and John Jumper have been awarded the 2024 Nobel Prize for Chemistry. One half of the prize has been awarded to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.” Protein design. The remarkable work by David Baker and colleagues in computational protein design, which recently has been revolutionised by Al, has made it possible to custom-build protein according to a researchers specifications...

Since 1995, the Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, has honored outstanding achievements in the field of biomedical research in Europe once a year. The Eppendorf Award for Young European Investigators is presented in collaboration with Nature. Scientists up to the age of 35 with an advanced degree, who are conducting research in Europe, can apply from October 1, 2024 to January 15, 2025 online...

At the 36th annual European Congress of Pathology in Florence, Italy, Thermo Fisher Scientific, the world leader serving science, announced the latest recipients of the Oncomine Clinical Research Grant, designed to support emerging research on molecular profiling in oncology and to help democratize the future of precision medicine. Now in its fourth year, the grant recognizes research from Tata Memorial Centre in India; Leiden University Center in The Netherlands; Western University in Canada; and Fred Hutch Cancer Center in the U.S...

Azenta, I nc. has announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide comprehensive proteomics profiling on up to 20,000 individuals...